Metastatic cancer

Common Name(s)

Metastatic cancer

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Metastatic cancer" returned 5276 free, full-text research articles on human participants. First 3 results:

The role of third-line chemotherapy in recurrent or metastatic gastric cancer: A cohort study with propensity score matching analysis.
 

Author(s): Yong Won Choi, Mi Sun Ahn, Geum Sook Jeong, Hyun Woo Lee, Seong Hyun Jeong, Seok Yun Kang, Joon Seong Park, Jin-Hyuk Choi, Seung Soo Sheen

Journal: Medicine (Baltimore). 2018 Sep;97(39):e12588.

 

In recurrent or metastatic gastric cancer, second-line chemotherapy is generally recommended in current guidelines. Although third-line therapy is often performed in daily practice in some countries, there are only a few reports about its benefits.A retrospective review was conducted ...

Last Updated: 31 Dec 1969

Go To URL
Triplet Chemotherapy (FOLFOXIRI) Plus Bevacizumab Versus Doublet Chemotherapy (FOLFOX/FOLFIRI) Plus Bevacizumab in Conversion Therapy for Metastatic Colorectal Cancer: a Meta-Analysis.
 

Author(s): Lin Shui, Yu-Shen Wu, Huapeng Lin, Pixian Shui, Qin Sun, Xiaopin Chen

Journal: Cell. Physiol. Biochem.. 2018 ;48(5):1870-1881.

 

Conversion therapy can convert unresectable metastatic colorectal cancer (mCRC) into resectable. However, the optimal conversion regimen was not yet defined. This meta-analysis aimed to compare the efficacy and safety of the triplet chemotherapy (FOLFOXIRI) plus bevacizumab (Bev) ...

Last Updated: 31 Dec 1969

Go To URL
[Metastatic nasopharynx cancer at diagnosis: clinical and prognostic (study of 51 cases)].
 

Author(s): Noureddine Bouaouina, Sarra Ouni, Samia Belajouza Kanoun, Abir Ben Neffeti, Wassim Kermani, Mohamed Abdelkefi

Journal:

 

This retrospective study aimed to highlight the different epidemiological, clinical, therapeutic and prognostic features of nasopharinx cancer with inaugural metastases in patients hospitalized in a Tunisian Hospital. We here report 51 cases of histologically diagnosed nasopharynx ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Metastatic cancer" returned 604 free, full-text review articles on human participants. First 3 results:

Everolimus-based combination therapies for HR+, HER2- metastatic breast cancer.
 

Author(s): Joyce O'Shaughnessy, J Thaddeus Beck, Melanie Royce

Journal: Cancer Treat. Rev.. 2018 Sep;69():204-214.

 

Metastatic breast cancer (MBC) is the leading cause of cancer-related morbidity and mortality among women worldwide. Endocrine therapy is the standard of care for the most common subtype of MBC, hormone-receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) ...

Last Updated: 31 Dec 1969

Go To URL
Effectiveness of Platinum-Based Treatment for Triple Negative Metastatic Breast Cancer: a Meta-Analysis
 

Author(s): Vildan Kaya, Mustafa Yildirim, Gozde Yazici, Seyda Gunduz, Hakan Bozcuk, Semra Paydas

Journal:

 

Background: Triple-negative breast cancer (TNBC) is a sub-group of breast cancers with a particularly poor prognosis. The results of studies investigating the role of platinum-based chemotherapy (PBC) in metastatic TNBC (mTNBC) have been conflicting. In this meta-analysis, our aim ...

Last Updated: 31 Dec 1969

Go To URL
Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches.
 

Author(s): Zool Hilmi Awang, Markus Essler, Hojjat Ahmadzadehfar

Journal:

 

Prostate Cancer is the forth most common type of cancer. Prostate-specific membrane antigen (PSMA) is anchored in the cell membrane of prostate epithelial cells. PSMA is highly expressed on prostate epithelial cells and strongly up-regulated in prostate cancer. Therefore it is an ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 3 Aug 2018

Go to URL
Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.
 

Status: Recruiting

Condition Summary: Metastatic Cancer

 

Last Updated: 15 Feb 2017

Go to URL